Intravenous Immunoglobulins after Liver Transplantation: new insights in mechanisms of action
Year: 2009
Type: dissertation
Abstract: The principal concept of organ transplantation is the replacement of a diseased organ with a\nhealthy one from another individual. In recent decades, transplantation has saved the lives of\nthousands of people who otherwise were condemned to death because of their life-threatening\ndiseases. Currently, liver transplantation is the treatment of choice for both acute and chronic\nliver failure. The first successful transplantation of a liver in human was performed by Thomas\nStarzl in 1967 1. In 1983 the National Institutes of Health (NIH) declare liver transplantation as\nan accepted therapy for end-stage liver disease 2. From the last two decades, most important\nindications for liver transplantation in Europe were cirrhosis (58%), cancer (13%), cholestatic\ndiseases (11%) and acute hepatic failure (9%). Survival is excellent both in short term and\nlong term transplant patients, with patient survival rates of approximately 81% one year after\nsurgery, and 69% five years after transplantation (source: www.eltr.org).
Author: T. Tha‐In
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2102331349